Please enable Javascript
Upper Tract Urothelial Carcinoma
Advertisement
Neoadjuvant Versus Adjuvant Chemotherapy in Patients With UTUC and Previous Radical Nephroureterectomy
Emily Menendez
Upper Tract Urothelial Carcinoma
|
March 10, 2023
A team of researchers set out to determine the preferred sequence of perioperative systemic therapy for node-positive UTUC.
Read More
Novel Mitomycin-Based Therapy Shows Promise As “Game-Changing” Option for UTUC
Yair Lotan, MD
Upper Tract Urothelial Carcinoma
|
February 10, 2023
Yair Lotan, MD, details the real-world use, effectiveness, and standard-of-care potential of UGN-101 for patients with UTUC.
Read More
Jonathan Coleman, MD – Pioneering New Understandings of Upper Tract Urothelial Carcinoma
Jonathan Coleman, MD
Upper Tract Urothelial Carcinoma
|
February 7, 2023
Dr. Coleman shares his unique career path, his role in defining UTUC, and ongoing research to improve patient outcomes.
Read More
Total Intracorporeal Versus Open Bladder Cuffing in Robotic Radical Nephroureterectomy for UTUC
Zachary Bessette
Upper Tract Urothelial Carcinoma
|
January 25, 2023
Intracorporeal DUBC may be a safe and effective alternative to RNU for UTUC, according to a new research.
Read More
Neoadjuvant Chemotherapy Combo Is Safe, Effective in High-Grade UTUC
Zachary Bessette
Upper Tract Urothelial Carcinoma
|
January 6, 2023
Neoadjuvant chemotherapy with gemcitabine and split-dose cisplatin is well-tolerated and effective in patients with UTUC.
Read More
Delay from Upper Tract Urothelial Cancer Diagnosis to Surgery Linked with Poor Outcomes
Leah Lawrence
Upper Tract Urothelial Carcinoma
|
December 13, 2022
A delay in definitive radical cystectomy or radical nephro-ureterectomy is associated with poor survival in UTUC patients.
Read More
High B2-Microglobulin Levels Associated With UTUC Recurrence and Metastasis
Emily Menendez
Upper Tract Urothelial Carcinoma
|
November 30, 2022
A research team recently investigated the use of tubular damage biomarkers as prognostic markers for upper tract UC.
Read More
Survival Impact of Variant Histology Diagnosis in UTUC
Daniel Tennenbaum, MD
Journal
|
November 22, 2022
Up to one-third of all UTUC patients present with variant histology, such as squamous or micropapillary features.
Read More
UTUC and Variant Histology
Akhil Abraham Saji, MD
Journal
|
November 22, 2022
1 of 4 will UTUC patients will have a variant histologic subtype such as squamous cell, micropapillary, or neuroendocrine.
Read More
Evidence Lacking on Value of Radiotherapy in Upper Tract Urothelial Carcinoma
Leah Lawrence
Upper Tract Urothelial Carcinoma
|
November 15, 2022
Out of 17 studies, adjuvant radiotherapy had no significant effect on UTUC, and radiotherapy had a negative impact on OS.
Read More
Site of Metastases Affected Survival in Metastatic Upper Tract Urothelial Carcinoma
Leah Lawrence
Upper Tract Urothelial Carcinoma
|
October 18, 2022
Among patients with mUTUC, a distant lymph node was the most common site of single-organ metastases.
Read More
Robotic Nephroureterectomy in the Management of Upper Tract Urothelial Cancer: Inching Toward Standard of Care?
GU Oncology Now Editors
Upper Tract Urothelial Carcinoma
|
May 25, 2022
Since 2006, the surgical technique and the robotic surgical system has gone through a major evolution.
Read More
Immunohistochemistry Parameters-Based Classifier to Predict Local-Recurrence of UTUC After Kidney-Sparing Surgery
GU Oncology Now Editors
Upper Tract Urothelial Carcinoma
|
May 23, 2022
The study examined the construction and verification of a new nomogram established to predict the local recurrence risk.
Read More
Advertisement
Advertisement
Advertisement